These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 33863622)
1. The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment. Cardoso AP; Pinto ML; Castro F; Costa ÂM; Marques-Magalhães Â; Canha-Borges A; Cruz T; Velho S; Oliveira MJ Cytokine Growth Factor Rev; 2021 Aug; 60():107-119. PubMed ID: 33863622 [TBL] [Abstract][Full Text] [Related]
2. CCL18 in the Progression of Cancer. Korbecki J; Olbromski M; Dzięgiel P Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114763 [TBL] [Abstract][Full Text] [Related]
3. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer. Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449 [TBL] [Abstract][Full Text] [Related]
4. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma. Meng F; Li W; Li C; Gao Z; Guo K; Song S Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147 [TBL] [Abstract][Full Text] [Related]
5. Surgical trauma-induced CCL18 promotes recruitment of regulatory T cells and colon cancer progression. Sun Z; Du C; Xu P; Miao C J Cell Physiol; 2019 Apr; 234(4):4608-4616. PubMed ID: 30216450 [TBL] [Abstract][Full Text] [Related]
6. Chemokine (CC motif) ligand 18 upregulates Slug expression to promote stem-cell like features by activating the mammalian target of rapamycin pathway in oral squamous cell carcinoma. Wang H; Liang X; Li M; Tao X; Tai S; Fan Z; Wang Z; Cheng B; Xia J Cancer Sci; 2017 Aug; 108(8):1584-1593. PubMed ID: 28574664 [TBL] [Abstract][Full Text] [Related]
7. CC-chemokine ligand 18 induces epithelial to mesenchymal transition in lung cancer A549 cells and elevates the invasive potential. Ploenes T; Scholtes B; Krohn A; Burger M; Passlick B; Müller-Quernheim J; Zissel G PLoS One; 2013; 8(1):e53068. PubMed ID: 23349697 [TBL] [Abstract][Full Text] [Related]
8. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands. Korbecki J; Grochans S; Gutowska I; Barczak K; Baranowska-Bosiacka I Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076281 [TBL] [Abstract][Full Text] [Related]
9. Decellularized human colorectal cancer matrices polarize macrophages towards an anti-inflammatory phenotype promoting cancer cell invasion via CCL18. Pinto ML; Rios E; Silva AC; Neves SC; Caires HR; Pinto AT; Durães C; Carvalho FA; Cardoso AP; Santos NC; Barrias CC; Nascimento DS; Pinto-do-Ó P; Barbosa MA; Carneiro F; Oliveira MJ Biomaterials; 2017 Apr; 124():211-224. PubMed ID: 28209528 [TBL] [Abstract][Full Text] [Related]
10. Tumor-Derived Extracellular Vesicles Induce CCL18 Production by Mast Cells: A Possible Link to Angiogenesis. Shefler I; Salamon P; Zitman-Gal T; Mekori YA Cells; 2022 Jan; 11(3):. PubMed ID: 35159163 [TBL] [Abstract][Full Text] [Related]
11. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy. Morein D; Erlichman N; Ben-Baruch A Front Immunol; 2020; 11():952. PubMed ID: 32582148 [TBL] [Abstract][Full Text] [Related]
12. Interaction Between CCL18 and GPR30 Differs from the Interaction Between Estradiol and GPR30. Schmidt-Wolf R; Zissel G Anticancer Res; 2020 Jun; 40(6):3097-3108. PubMed ID: 32487604 [TBL] [Abstract][Full Text] [Related]
13. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway. Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093 [TBL] [Abstract][Full Text] [Related]
14. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy. Bule P; Aguiar SI; Aires-Da-Silva F; Dias JNR Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575965 [TBL] [Abstract][Full Text] [Related]
16. CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling. Lane D; Matte I; Laplante C; Garde-Granger P; Carignan A; Bessette P; Rancourt C; Piché A Mol Cancer; 2016 Sep; 15(1):58. PubMed ID: 27613122 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer. Pham TH; Bak Y; Kwon T; Kwon SB; Oh JW; Park JH; Choi YK; Hong JT; Yoon DY Cell Commun Signal; 2019 May; 17(1):53. PubMed ID: 31126309 [TBL] [Abstract][Full Text] [Related]
18. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway. Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613 [TBL] [Abstract][Full Text] [Related]
19. Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. Schutyser E; Richmond A; Van Damme J J Leukoc Biol; 2005 Jul; 78(1):14-26. PubMed ID: 15784687 [TBL] [Abstract][Full Text] [Related]
20. CC chemokine ligand 18(CCL18) promotes migration and invasion of lung cancer cells by binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway. Shi L; Zhang B; Sun X; Zhang X; Lv S; Li H; Wang X; Zhao C; Zhang H; Xie X; Wang Y; Zhang P Mol Carcinog; 2016 Dec; 55(12):2051-2062. PubMed ID: 26756176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]